for Sponsor Initiated Trials
mint Lesion™ is designed to facilitate research in clinical trials with imaging endpoints. This includes the transfer and storage of clinical trial DICOM data, a workflow optimized for consistent interpretation and reviewing of image findings, the reviewing of image meta-data, and the simplified provision of results to physicians and other clinical systems, e.g. PACS and Clinical Trial Management Systems. mint Lesion™ thus implements the functionality of a Clinical Trial Image Management System (CTIMS) as defined by the NCI.
mint Lesion™ allows you to model the needs of your imaging charter by software configuration. Have dedicated medical experts, tasks, workflows, and permissions set up and let mint Lesion drive your imaging research – from image quality assurance and eligibility read up to patient cohort level data export and reader metrics.
Objective Radiological Read
The context-driven read procedures of mint Lesion™ will guide the radiological expert to perform a dedicated assessment in an optimized read context. Significant observations in morphologic and functional image data are documented and classified in adherence to the protocol and tracked throughout treatment. By this means, mint Lesion™ provides the basis for a true objective assessment and minimizes reader variability. Let mint Lesion help your readers to speed up their work and focus on their job-to-be-done.
Monitoring & Data Management
Monitoring project progress directly within mint Lesion™ will increase the efficiency of your research work. As one example, corrective actions are managed, performed, and documented in immediate correlation with the image annotations to assure traceability and integrity of your research data. Comprehensive and high quality data is crucial in clinical research. mint Lesion™ generates this data for a single observation on image data up to comprehensive data exports for the entire study cohort. An automated response assessment automatically assigns the time-point response from lesion measurements and classifications to avoid manual calculations.
Achieve high quality research results with mint Lesion™, the single dedicated Clinical Trial Imaging System in line with CFR Part 11, GxP, and HIPAA as approved medical device
(FDA 510k, CE)
Phase 1 Trials
Phase 2 Trials
Phase 3 Trials
Overall approved reads